Condition
Pseudomyxoma Peritonei clinical trials and research
As of November 12, 2026, Find a Trial lists 9 Pseudomyxoma Peritonei clinical trials that are recruiting, at sites in 7 countries (most in United States (2), Norway (2), China (1)). By phase: Phase 2 (2), Phase 3 (1), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 7Countries
Newest Pseudomyxoma Peritonei clinical trials
All recruiting trials (9)
-
Appendix Cancer and PMP Patient Registry and Natural History Study
This global, patient-powered registry tests how appendix cancer and pseudomyxoma peritonei progress over time by collecting real-world data from patients and caregivers.
-
Metformin in PMP from appendiceal mucinous neoplasms
This pilot study tests whether metformin is feasible to use in adults with pseudomyxoma peritonei caused by appendiceal mucinous tumors who have recurrent or unresected disease.
-
Pseudovax: a vaccine for people with pseudomyxoma peritonei
This trial will test whether the Pseudovax peptide vaccine with GM‑CSF plus the PD‑1 drug tislelizumab can boost anti‑tumor immunity in adults with GNAS‑mutated pseudomyxoma peritonei.
-
One versus three HIPEC cycles after cytoreductive surgery for pseudomyxoma peritonei
This study will see if giving three HIPEC sessions instead of one after cytoreductive surgery helps people with pseudomyxoma peritonei live longer, delay disease progression, and keep a better quality of life.
-
Neoadjuvant treatment for patients with advanced Pseudomyxoma peritonei
This study is testing a new combination of medications to see if it can help patients with advanced Pseudomyxoma peritonei have better surgery results.
-
Comparing low-dose and high-dose chemotherapy for treating Pseudomyxoma Peritonei
This study is testing if a lower dose of chemotherapy given for a shorter time can work just as well as a higher dose for treating Pseudomyxoma Peritonei.
-
Using cardiac coherence to reduce anxiety in patients with peritoneal carcinosis before surgery
This study is testing if teaching patients with peritoneal carcinosis some breathing techniques can help reduce their anxiety before surgery.
-
Identifying biomarkers and treatment strategies for peritoneal surface malignancies
This study is trying to find specific markers in patients with peritoneal surface cancers to help choose the best treatment options and improve their chances of recovery.
-
Registering patients undergoing heated chemotherapy for peritoneal cancers
This study is collecting information from patients with certain abdominal cancers who are having surgery followed by heated chemotherapy to see if it helps them live longer and feel better.
Related topics
Quick answers
How many Pseudomyxoma Peritonei clinical trials are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in United States (2 trials), Norway (2 trials), China (1 trial), United Kingdom (1 trial), Belgium (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 3: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.